Research led by Suresh Alahari, PhD, Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health New Orleans School of Medicine, has demonstrated the potential of a protein to treat or prevent metabolic diseases including obesity and diabetes.
The findings are published online in the Journal of Biological Chemistry as a Paper in Press, available here. Nischarin is a novel protein discovered by the Alahari lab. The research team demonstrated that it functions as a molecular scaffold that holds and interacts with several protein partners in a number of biological processes. The lab’s earlier research found that Nischarin acts as a tumor suppressor that may inhibit the spread, or metastasis, of breast and other cancers.
“These studies demonstrate the potential of Nischarin as a regulator of metabolic diseases and suggest suppression of Nischarin function may be a valuable approach in the quest to cure such diseases as diabetes and obesity,” notes Dr. Alahari.According to the National Health and Nutrition Examination Survey (NHANES), 2013–2014, more than 2 in 3 US adults (70.2 percent) were considered to be overweight or obese. The American Diabetes Association says that in 2015, 30.3 million Americans, or 9.4% of the population, had diabetes.
The Latest on: Nischarin
- International journal of obesity (2005)on November 25, 2020 at 4:00 pm
Greater blood volume and Hb mass in obese women quantified by the carbon monoxide-rebreathing method affects interpretation of iron biomarkers and iron requirements.
- Mammary Gland News and Researchon October 15, 2020 at 5:00 pm
may be effective in treating cancers that lack a protein called Nischarin. ChromaDex Corp. today reported that results of a first-of-a-kind preclinical study on lactation have shown that ...
via Google News and Bing News